+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats



Pharmacologic antagonism of ghrelin receptors attenuates development of nicotine induced locomotor sensitization in rats



Regulatory Peptides 172(1-3): 77-80



Ghrelin (GHR) is an orexigenic gut peptide that interacts with ghrelin receptors (GHR-Rs) to modulate brain reinforcement circuits. Systemic GHR infusions augment cocaine stimulated locomotion and conditioned place preference (CPP) in rats, whereas genetic or pharmacological ablation of GHR-Rs has been shown to attenuate the acute locomotor-enhancing effects of nicotine, cocaine, amphetamine and alcohol and to blunt the CPP induced by food, alcohol, amphetamine and cocaine in mice. The stimulant nicotine can induce CPP and like amphetamine and cocaine, repeated administration of nicotine induces locomotor sensitization in rats. A key issue is whether pharmacological antagonism of GHR-Rs would similarly attenuate nicotine-induced locomotor sensitization. To examine the role of GHR-Rs in the behavioral sensitizing effects of nicotine, adult male rats were injected with either 0, 3 or 6 mg/kg of the GHR-R receptor antagonist JMV 2959 (i.p.) and 20 min later with either vehicle or 0.4 mg/kg nicotine hydrogen tartrate (s.c.) on each of 7 consecutive days. Rats treated with nicotine alone showed robust locomotor sensitization, whereas rats pretreated with JMV 2959 showed significantly attenuated nicotine-induced hyperlocomotion. These results suggest that GHR-R activity is required for the induction of locomotor sensitization to nicotine and complement an emerging literature implicating central GHR systems in drug reward/reinforcement.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036197445

Download citation: RISBibTeXText

PMID: 21903141

DOI: 10.1016/j.regpep.2011.08.014


Related references

Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addiction Biology 17(6): 956-963, 2012

Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug and Alcohol Dependence 117(2-3): 126-131, 2011

Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats. European Journal of Pharmacology 812: 28-37, 2017

Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats. Synapse 63(1): 15-21, 2008

Effects of risperidone on development and expression of nicotine-induced locomotor sensitization in rats. Synapse 65(8): 708-714, 2011

Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats. Pharmaceutical Biology 57(1): 8, 2019

The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. Plos one 8(10): E77284, 2013

Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 211(4): 415-422, 2010

The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats. Neuropharmacology 61(3): 451-457, 2011

Intra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats. Frontiers in Microbiology 6: 540, 2015

Blockade of adenosine A2A receptors attenuates amphetamine - induced locomotor sensitization in two mouse strains. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 916 8, 2003

Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats. Psychopharmacology 198(4): 461-466, 2008

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. European Journal of Pharmacology 458(1-2): 111-118, 1 January, 2003

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. European Journal of Pharmacology 458(1-2): 111-118, 2003

Impact of baseline prepulse inhibition on nicotine-induced locomotor sensitization in rats. Behavioural Brain Research 216(1): 275-280, 2011